[1] Doty RL, Deems DA, Stellar S. Olfactory dysfunction in parkinsonism:a general deficit unrelated to neurologic signs, disease stage, or disease duration[J]. Neurology, 1988, 38:1237-1244. [2] Haehner A, Boesveldt S, Berendse HW, Mackay-Sim A, Fleischmann J, Silburn PA, Johnston AN, Mellick GD, Herting B, Reichmann H, Hummel T. Prevalence of smell loss in Parkinson's disease:a multicenter study[J]. Parkinsonism Relat Disord, 2009, 15:490-494. [3] Tissingh G, Berendse HW, Bergmans P, DeWaard R, Drukarch B, Stoof JC, Wolters EC. Loss of olfaction in de novo and treated Parkinson's disease:possible implications for early diagnosis[J]. Mov Disord, 2001, 16:41-46. [4] Millar Vernetti P, Perez Lloret S, Rossi M, Cerquetti D, Merello M. Validation of a new scale to assess olfactory dysfunction in patients with Parkinson's disease[J]. Parkinsonism Relat Disord, 2012, 18:358-361. [5] Cao M, Wang N, Zheng P, Gu Z, Chan P. Validation of a new olfactory test for Chinese Parkinson's disease patients[J]. J Clin Neurosci, 2020, 76:31-35. [6] Parkinson's Disease and Movement Disorders Group, Neurology Branch, Chinese Medical Association; Parkinson's Disease and Movement Disorders Specialty, Neurology Branch, Chinese Medical Doctor Association. Diagnostic criteria for Parkinson's disease in China (2016 edition)[J]. Zhonghua Shen Jing Ke Za Zhi, 2016, 49:268-271.[中华医学会神经病学分会帕金森病及运动障碍学组, 中国医师协会神经内科医师分会帕金森病及运动障碍专业. 中国帕金森病的诊断标准(2016版)[J]. 中华神经科杂志, 2016, 49:268-271.] [7] Martínez-Martín P, Rodríguez-Blázquez C, Mario Alvarez, Arakaki T, Arillo VC, Chaná P, Fernández W, Garretto N, Martínez-Castrillo JC, Rodríguez-Violante M, Serrano-Dueñas M, Ballesteros D, Rojo-Abuin JM, Chaudhuri KR, Merello M. Parkinson's disease severity levels and MDS-Unified Parkinson's Disease Rating Scale[J]. Parkinsonism Relat Disord, 2015, 21:50-54. [8] Double KL, Rowe DB, Hayes M, Chan DK, Blackie J, Corbett A, Joffe R, Fung VS, Morris J, Halliday GM. Identifying the pattern of olfactory deficits in Parkinson disease using the brief smell identification test[J]. Arch Neurol, 2003, 60:545-549. [9] Silveira-Moriyama L, Williams D, Katzenschlager R, Lees A. Pizza, mint, and licorice:smell testing in Parkinson's disease in a UK population[J]. Mov Disord, 2005, 20:S139. [10] Bohnen NI, Gedela S, Herath P, Constantine GM, Moore RY. Selective hyposmia in Parkinson disease:association with hippocampal dopamine activity[J]. Neurosci Lett, 2008, 447:12-16. [11] Hähner A, Maboshe W, Baptista RB, Storch A, Reichmann H, Hummel T. Selective hyposmia in Parkinson's disease[J]? J Neurol, 2013, 260:3158-3160. [12] Braun T, Doerr JM, Peters L, Viard M, Reuter I, Prosiegel M, Weber S, Yeniguen M, Tschernatsch M, Gerriets T, Juenemann M, Huttner HB, Hamzic S. Age-related changes in oral sensitivity, taste and smell[J]. Sci Rep, 2022, 12:1533. [13] Kanavou S, Pitz V, Lawton MA, Malek N, Grosset KA, Morris HR, Ben-Shlomo Y, Grosset DG. Comparison between four published definitions of hyposmia in Parkinson's disease[J]. Brain Behav, 2021, 11:e2258. [14] Herting B, Schulze S, Reichmann H, Haehner A, Hummel T. A longitudinal study of olfactory function in patients with idiopathic Parkinson's disease[J]. J Neurol, 2008, 255:367-370. [15] Campabadal A, Uribe C, Segura B, Baggio HC, Abos A, Garcia-Diaz AI, Marti MJ, Valldeoriola F, Compta Y, Bargallo N, Junque C. Brain correlates of progressive olfactory loss in Parkinson's disease[J]. Parkinsonism Relat Disord, 2017, 41:44-50. [16] Lucassen EB, Sterling NW, Lee EY, Chen H, Lewis MM, Kong L, Huang X. History of smoking and olfaction in Parkinson's disease[J]. Mov Disord, 2014, 29:1069-1074. [17] Roos DS, Twisk JWR, Raijmakers PGHM, Doty RL, Berendse HW. Hyposmia as a marker of (non-)motor disease severity in Parkinson's disease[J]. J Neural Transm (Vienna), 2019, 126:1471-1478. [18] Domellöf ME, Lundin KF, Edström M, Forsgren L. Olfactory dysfunction and dementia in newly diagnosed patients with Parkinson's disease[J]. Parkinsonism Relat Disord, 2017, 38:41-47. [19] Schrag A, Siddiqui UF, Anastasiou Z, Weintraub D, Schott JM. Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson's disease:a cohort study[J]. Lancet Neurol, 2017, 16:66-75. |